John Couling - Oct 3, 2022 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Signature
/s/ Daniel Rodriguez, Attorney-in-Fact for John Couling
Stock symbol
DLB
Transactions as of
Oct 3, 2022
Transactions value $
-$1,869,904
Form type
4
Date filed
10/5/2022, 06:53 PM
Previous filing
May 17, 2022
Next filing
Nov 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Options Exercise $893K +29.3K +36.98% $30.49 109K Oct 3, 2022 Direct F1
transaction DLB Class A Common Stock Sale -$1.94M -29.3K -27% $66.30 79.2K Oct 3, 2022 Direct F1, F2
transaction DLB Class A Common Stock Options Exercise $686K +20.7K +26.12% $33.15 99.9K Oct 3, 2022 Direct F1
transaction DLB Class A Common Stock Sale -$567K -8.68K -8.69% $65.33 91.3K Oct 3, 2022 Direct F1, F3
transaction DLB Class A Common Stock Sale -$791K -12K -13.17% $65.81 79.2K Oct 3, 2022 Direct F1, F4
transaction DLB Class A Common Stock Options Exercise $143K +4.3K +5.43% $33.15 83.5K Oct 4, 2022 Direct F1
transaction DLB Class A Common Stock Sale -$291K -4.3K -5.15% $67.72 79.2K Oct 4, 2022 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DLB Employee Stock Option (right to buy) Options Exercise $0 -29.3K -100% $0.00* 0 Oct 3, 2022 Class A Common Stock 29.3K $30.49 Direct F6
transaction DLB Employee Stock Option (right to buy) Options Exercise $0 -20.7K -82.8% $0.00 4.3K Oct 3, 2022 Class A Common Stock 20.7K $33.15 Direct F7
transaction DLB Employee Stock Option (right to buy) Options Exercise $0 -4.3K -100% $0.00* 0 Oct 4, 2022 Class A Common Stock 4.3K $33.15 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest.
F2 This transaction was executed in multiple trades at prices ranging from $65.91 to $66.655. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 This transaction was executed in multiple trades at prices ranging from $64.69 to $65.685. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F4 This transaction was executed in multiple trades at prices ranging from $65.69 to $65.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F5 This transaction was executed in multiple trades at prices ranging from $67.20 to $67.945. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F6 This option was granted for a total of 49,300 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on each anniversary of December 21, 2012, the vesting commencement date.
F7 This performance-based stock option award was granted for a total of 20,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 25,000 shares.

Remarks:

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.